Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914

The effect of age on the non-haemin iron in the human brain

Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,377

FERRITIN: STRUCTURE, GENE REGULATION, AND CELLULAR FUNCTION IN ANIMALS, PLANTS, AND MICROORGANISMS

Theil, E. C. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.001445 · Cited by 1,337

Increased nigral iron content in postmortem parkinsonian brain

Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963

Autoxidation versus Covalent Binding of Quinones as the Mechanism of Toxicity of Dopamine, 6-Hydroxydopamine, and Related Compounds toward C1300 Neuroblastoma Cells in Vitro

Graham, D. G., Tiffany, S. M., BELL, W. R., & Gutknecht, W. F. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13536-0 · Cited by 953

The importance of free radicals and catalytic metal ions in human diseases.

Halliwell, B., & Gutteridge, J. M. C. (1985) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(85)90001-9 · Cited by 941

Iron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation

Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, R. D., & Harford, J. B. (1988) · Science · doi:10.1126/science.2452485 · Cited by 709

Brain Peroxidase and Catalase in Parkinson Disease

Ambani, L. M., Woert, M. H. V., & Murphy, S. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490440064010 · Cited by 404

New horizons in molecular mechanisms underlying Parkinson’s disease and in our understanding of the neuroprotective effects of selegiline

Gerlach, M., Desser, H., Youdim, M. B. H., & Riederer, P. F. (1996) · Springer eBooks · doi:10.1007/978-3-7091-7494-4_2 · Cited by 22

Chapter 16 Neurodegeneration and glutamate induced oxidative stress

Nakao, N., & Brundin, P. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)60441-0 · Cited by 22

The thiobarbituric acid assay reflects susceptibility to oxygen induced lipid peroxidation in vitro rather than levels of lipid hydroperoxides in vivo: A methodological approach

Götz, M. E., Dirr, A., Freyberger, A., Burger, R., & Riederer, P. F. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90053-8 · Cited by 22

Elemental quantification and analysis of structural abnormalities in neurons from Parkinson’s-diseased brains by X-ray fluorescence microscopy and diffraction

Joppe, K., Nicolas, J., Grünewald, T. A., Eckermann, M., Salditt, T., & Lingor, P. (2020) · Biomedical Optics Express · doi:10.1364/boe.389408 · Cited by 21

Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson’s Disease

González-Alcocer, A., Duarte-Jurado, A. P., Soto‐Domínguez, A., Loera‐Arias, M. D. J., Villarreal‐Silva, E. E., Cárdenas, O. S., Montes‐de‐Oca‐Luna, R., García‐García, A., & Rodríguez‐Rocha, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021256 · Cited by 22

Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?

Heise, C. E., Teo, Z. C., Wallace, B. A., Ashkan, K., Benabid, A., & Mitrofanis, J. (2005) · Anatomy and Embryology · doi:10.1007/s00429-005-0053-1 · Cited by 21

Parkinson's disease: emerging pharmacotherapy

Strecker, K., & Schwarz, J. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210802596906 · Cited by 21

Iron-mediated interaction of alpha synuclein with lipid raft model membranes

Perissinotto, F., Stani, C., Cecco, E. D., Vaccari, L., Rondelli, V., Posocco, P., Parisse, P., Scaini, D., Legname, G., & Casalis, L. (2020) · Nanoscale · doi:10.1039/d0nr00287a · Cited by 21

Mitophagy and iron: two actors sharing the stage in age-associated neuronal pathologies

Schiavi, A., Strappazzon, F., & Ventura, N. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111252 · Cited by 22

Pharmacological but not physiological concentrations of melatonin reduce iron-induced neuronal death in rat cerebral cortex

Hayter, C. L., Bishop, G. M., & Robinson, S. R. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.02.024 · Cited by 21

Identification of an NADH plus iron dependent, Ca2+ activated hydrogen peroxide production in synaptosomes

Zoccarato, F., Valente, M., & Alexandre, A. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90046-r · Cited by 21

Potential of Neuroprotective Therapy in Parkinsonʼs Disease

Mizuno, Y., Mori, H., & Kondo, T. (1994) · CNS Drugs · doi:10.2165/00023210-199401010-00005 · Cited by 21

High-resolution mapping of substantia nigra in Parkinson’s disease using 7 tesla magnetic resonance imaging

Madelung, C. F., Løkkegaard, A., Fuglsang, S. A., Marques, M. M., Boer, V. O., Madsen, K. H., Hejl, A., Meder, D., & Siebner, H. R. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00972-7 · Cited by 20

Differential Effect of Iron and Myelin on Susceptibility MRI in the Substantia Nigra

Lee, H., Cho, H., Lee, M. J., Kim, T.-H., Roh, J., & Lee, J. (2021) · Radiology · doi:10.1148/radiol.2021210116 · Cited by 20

Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach

Forero-Rodríguez, L. J., Josephs‐Spaulding, J., Flor, S., Pinzón, A. M., & Kaleta, C. (2021) · Antioxidants · doi:10.3390/antiox11010071 · Cited by 23

The Zinc Ionophore Clioquinol Reduces Parkinson’s Disease Patient-Derived Brain Extracts-Induced Neurodegeneration

Teil, M., Doudnikoff, É., Thiolat, M.-L., Bohic, S., Bézard, E., & Dehay, B. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02974-5 · Cited by 20

Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice

Sharma, M., Sharma, N., & Khairnar, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03847-y · Cited by 20

Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis

Carmona, A., Carboni, E., Gomes, L. C., Roudeau, S., Maass, F., Lenz, C., Ortega, R., & Lingor, P. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16040 · Cited by 20

Soot nanoparticles promote ferroptosis in dopaminergic neurons via alteration of m6A RNA methylation in Parkinson’s disease

Feng, J., Zhang, P., Chen, K., Huang, P., Liang, X., Dong, J., Zhu, B., Fu, Z., Deng, T., Zhu, L., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134691 · Cited by 20

Modulation effect of substantia nigra iron deposition and functional connectivity on putamen glucose metabolism in Parkinson's disease

Zang, Z., Song, T., Li, J., Yan, S., Nie, B., Mei, S., Ma, J., Yu, Y., Shan, B., Zhang, Y., et al. (2022) · Human Brain Mapping · doi:10.1002/hbm.25880 · Cited by 20

Repin-Induced Neurotoxicity in Rodents

Robles, M., Choi, B. H., Han, B., Cruz, K. S., & Kim, R. C. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6826 · Cited by 20

PIXE analysis of human brain tissue

Boruchowska, M., Lankosz, M., Adamek, D., & Korman, A. (2001) · X-Ray Spectrometry · doi:10.1002/xrs.484 · Cited by 20

Thioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain

Seaton, T. A., Jenner, P. G., & MARSDEN, C. D. (1996) · Journal of Neural Transmission · doi:10.1007/bf01271243 · Cited by 20

Zn homeostasis in genetic models of Parkinson’s disease in Caenorhabditis elegans

Baesler, J., Kopp, J. F., Pohl, G., Aschner, M., Haase, H., Schwerdtle, T., & Bornhorst, J. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.05.005 · Cited by 18

Serum Cholesterol and Nigrostriatal R2* Values in Parkinson's Disease

Du, G., Lewis, M. M., Shaffer, M. L., Chen, H., Yang, Q. X., Mailman, R. B., & Huang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035397 · Cited by 19

Virus induces metal-binding proteins and changed trace element balance in the brain during the course of a common human infection (coxsackievirus B3) in mice

Ilbäck, N., Frisk, P., Mohamed, N., Gadhasson, I.-L., Blomberg, J., & Friman, G. (2007) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2007.03.025 · Cited by 19

Transcriptional Regulation of the Beta-Synuclein 5′-Promoter Metal Response Element by Metal Transcription Factor-1

McHugh, P., Wright, J. A., & Brown, D. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017354 · Cited by 19

Role of N-terminal methionine residues in the redox activity of copper bound to alpha-synuclein

Rodríguez, E. E., Arcos‐López, T., Trujano-Ortiz, L. G., Fernández, C. O., González, F. J., Vela, A., & Quintanar, L. (2016) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-016-1376-5 · Cited by 19

Pool size ratio of the substantia nigra in Parkinson’s disease derived from two different quantitative magnetization transfer approaches

Trujillo, P., Summers, P. E., Smith, A. K., Smith, S. A., Mainardi, L. T., Cerutti, S., Claassen, D. O., & Costa, A. (2017) · Neuroradiology · doi:10.1007/s00234-017-1911-2 · Cited by 22

Influence of organic acids on aluminium absorption and storage in rat tissues

Testolin, G., Erba, D., Ciappellano, S., & Bermano, G. (1996) · Food Additives & Contaminants · doi:10.1080/02652039609374378 · Cited by 19

Iron, cysteine and Parkinson’s disease

Jameson, G. N. L. (2011) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-011-0475-9 · Cited by 19

A rat brain fraction and different purified peroxidases catalyzing the formation of dopaminochrome from dopamine

Galzigna, L., Schiappelli, M. P., Rigo, A., & Scarpa, M. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00037-9 · Cited by 19

Treatment with the spin-trap agent α-phenyl-N-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons

Karlsson, J., Emgård, M., Rosenblad, C., & Brundin, P. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00702-1 · Cited by 19

Quantitative iron–neuromelanin MRI associates with motor severity in Parkinson's disease and matches radiological disease classification

Hartono, S., Chen, R. C., Welton, T., Tan, A. S., Lee, W., Teh, P. Y., Chen, C., Hou, W., Tham, W. P., Lim, E. W., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1287917 · Cited by 18

Iron deposition in subcortical nuclei of Parkinson’s disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies

Jin, J., Su, D., Zhang, J., Lam, J. S. T., Zhou, J., & Feng, T. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003167 · Cited by 18

Nifedipine Prevents Iron Accumulation and Reverses Iron-Overload-Induced Dopamine Neuron Degeneration in the Substantia Nigra of Rats

Ma, Z., Zhou, Y., & Xie, J. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9309-8 · Cited by 18

Oxidative Stress Regulated Iron Regulatory Protein IRP2 Through FBXL5-Mediated Ubiquitination-Proteasome Way in SH-SY5Y Cells

Jiao, Q., Du, X., Wei, J., Li, Y. H., & Jiang, H. F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00020 · Cited by 18

Sex-dependent compensated oxidative stress in the mouse liver upon deletion of catechol O-methyltransferase.

Tenorio-Laranga, J., Männistö, P., Karayiorgou, M., Gogos, J., & García-Horsman, J. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.02.004 · Cited by 19

Iron and cell death in Parkinson’s disease: a nuclear microscopic study into iron-rich granules in the parkinsonian substantia nigra of primate models

Thong, P. S. P., Watt, F., Ponraj, D., Leong, S. K., He, Y., & Lee, T. K. Y. (1999) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/s0168-583x(99)00390-0 · Cited by 18

Recovery by NO of the iron-attenuated dopamine dynamics in nigrostriatal system of rat brain

Lin, A. M. (1999) · Neuroscience Research · doi:10.1016/s0168-0102(99)00054-1 · Cited by 18

Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs

Thomas, C., Wurzer, L., Malle, E., Ristow, M., & Madreiter‐Sokolowski, C. T. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.905261 · Cited by 18

Quantitative imaging of Cu, Fe, Mn and Zn in the L-DOPA-treated unilateral 6-hydroxydopamine Parkinson's disease mouse model by LA-ICP-MS

Sussulini, A., Matusch, A., Klietz, M., Bauer, A., Depboylu, C., & Becker, J. S. (2012) · Biomedical Spectroscopy and Imaging · doi:10.3233/bsi-2012-0011 · Cited by 17

Iron modulates the activity of monoamine oxidase B in SH-SY5Y cells

Lu, H., Chen, J., Huang, H., Zhou, M., Zhu, Q. X., Yao, S. Q., Chai, Z., & Hu, Y. (2017) · BioMetals · doi:10.1007/s10534-017-0030-1 · Cited by 17

Enhanced Performance of CNT‐doped Imine Based Receptors as Fe(III) Sensor Using Potentiometry and Voltammetry

Mittal, S. K., Kumar, S., & Kaur, N. (2018) · Electroanalysis · doi:10.1002/elan.201800100 · Cited by 17

The determination of iron and other metals by INAA in Cortex, Cerebellum and Putamen of human brain and in their neuromelanins

Zecca, L., Tampellini, D., Rizzio, E., Giaveri, G., & Gallorini, M. (2001) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1023/a:1010650729843 · Cited by 17

Studies of interaction between iron (III) and intermediates of synthetic neuromelanin by means of cyclic voltammetry of and dopamine

Wang, J., Wang, Y., Lv, H., Hui, F., Ma, Y., Lu, S., Sha, Q., & Wang, E. (2006) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2006.05.021 · Cited by 17

Thermodynamic and Structural Characterization of the Specific Binding of Zn(II) to Human Protein DJ-1

Tashiro, S., Caaveiro, J. M. M., Wu, C., Hoang, Q. Q., & Tsumoto, K. (2014) · Biochemistry · doi:10.1021/bi500294h · Cited by 18

Intranigral iron infusion in the rat

Sengstock, G. J., Zawia, N. H., Olanow, C. W., Dunn, A. J., & Arendash, G. W. (1997) · Biological Trace Element Research · doi:10.1007/bf02917470 · Cited by 17

Is brain superoxide dismutase activity increased following chronic treatment with 1-deprenyl?

Lai, C., Zuo, D. M., & Yu, P. H. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9324-2_28 · Cited by 17

ATP13A2 (PARK9) and basal ganglia function

Croucher, K. M., & Fleming, S. M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2023.1252400 · Cited by 17

Exenatide-Modified Deferoxamine-Based Nanoparticles Ameliorates Neurological Deficits in Parkinson’s Disease Mice

Huang, Y., Wang, X., Li, W., Yue, F., Wang, M., & Zhou, F. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s479670 · Cited by 16

Serum Uric Acid Concentration is Linked to Wearing-off Fluctuation in Japanese Parkinson's Disease Patients

Fukae, J., Ishikawa, K., Hatano, T., Yoritaka, A., Takanashi, M., Shimo, Y., Tsugawa, J., Tsuboi, Y., & Hattori, N. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-140353 · Cited by 14

Abnormal iron accumulation in the brain of neonatal hypotransferrinemic mice

Takeda, A., Takatsuka, K., Connor, J. R., & Oku, N. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02719-6 · Cited by 16

Upregulation of Glutathione Peroxidase-1 Expression and Activity by Glial Cell Line–Derived Neurotrophic Factor Promotes High-Level Protection of PC12 Cells Against 6-Hydroxydopamine and Hydrogen Peroxide Toxicities

Gharib, E., Gardaneh, M., & Shojaei, S. (2013) · Rejuvenation Research · doi:10.1089/rej.2012.1390 · Cited by 16

Zinc Potentiates Lipopolysaccharide-induced Nitric Oxide Production in Cultured Primary Rat Astrocytes

Moriyama, M., Fujitsuka, S., Kawabe, K., Takano, K., & Nakamura, Y. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2431-5 · Cited by 16

A Smart Nanotherapeutic Agent for in vitro and in vivo Reversal of Heavy‐Metal‐Induced Causality: Key Information from Optical Spectroscopy

Adhikari, A., Biswas, P., Mondal, S., Das, M., Darbar, S., Hameed, A. M., Alharbi, A., Ahmed, S. A., Bhattacharya, S. S., Pal, D., et al. (2019) · ChemMedChem · doi:10.1002/cmdc.201900543 · Cited by 15

Highly sensitive sensing of Fe(III) harnessing Schiff based ionophore: An electrochemical approach supported with spectroscopic and DFT studies

Kaur, S., Shiekh, B. A., Kaur, D., & Kaur, I. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.115954 · Cited by 16

PPARδ Activation Mitigates 6-OHDA-Induced Neuronal Damage by Regulating Intracellular Iron Levels

Lee, W. J., Lee, H. G., Hur, J., Lee, G. H., Won, J. P., Kim, E., Hwang, J. S., & Seo, H. G. (2022) · Antioxidants · doi:10.3390/antiox11050810 · Cited by 15

Rôles biologiques des éléments traces dans le cerveau – exemples du Zn et du Fe

Bohic, S., Ghersi‐Egea, J., Gibon, J., Paoletti, P., Arnaud, J., Hunot, S., Boom, A., & Bouron, A. (2010) · Revue Neurologique · doi:10.1016/j.neurol.2010.07.035 · Cited by 16

Oxidative stress implication in a new phenotype of amyotrophic quadricipital syndrome with cardiac involvement due to lamin A/C mutation

Charniot, J.-C., Bonnefont‐Rousselot, D., Marchand‐Leroux, C., Zerhouni, K., Vignat, N., Peynet, J., Plotkine, M., Legrand, A., & Artigou, J. Y. (2006) · Free Radical Research · doi:10.1080/10715760601110046 · Cited by 16

Local striatal infusion of MPP+ does not result in increased hydroxylation after systemic administration of 4-hydroxybenzoate

Ste‐Marie, L., Vachon, L., Bémeur, C., Lambert, J., & Montgomery, J. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00170-7 · Cited by 16

The influence of electrical stimulation of vagus nerve on elemental composition of dopamine related brain structures in rats

Szczerbowska‐Boruchowska, M., Krygowska‐Wajs, A., Ziomber, A., Thor, P. J., Wróbel, P., Bukowczan, M., & Žižak, I. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.04.018 · Cited by 16

Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson’s disease induced by the Japanese encephalitis virus

Minami, M., Hamaue, N., Hirafuji, M., Saito, H., Hiroshige, T., Ogata, A., Tashiro, K., & Parvez, S. H. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_10 · Cited by 16

Differences between conventional and non conventional MRI techniques in Parkinson�s disease

Baglieri, A. (2013) · Functional Neurology · doi:10.11138/fneur/2013.28.2.073 · Cited by 16

Iron as a trigger of neurodegeneration in Parkinson's disease

Friedman, A., Gałązka-Friedman, J., & Bauminger, E. R. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83023-5 · Cited by 16

Modulation of DMT1 Activity by Redox Compounds

Marciani, P., Trotti, D., Hediger, M. A., & Monticelli, G. (2004) · The Journal of Membrane Biology · doi:10.1007/s00232-003-0644-9 · Cited by 16

Differential effects of transition metal cations on the conformation and biological activities of nerve growth factor

Maitra, R., Shamovsky, I. L., Wang, W., Solc, M., Lawrance, G. M., Dostaler, S. M., Ross, G. M., & Riopelle, R. J. (2000) · Neurotoxicity Research · doi:10.1007/bf03033341 · Cited by 16

Parkinson's Disease: From Etiology to Treatment.

Mizuno, Y., Mori, H., & Kondo, T. (1995) · Internal Medicine · doi:10.2169/internalmedicine.34.1045 · Cited by 16

Aluminum, Alzheimer's Disease and the Geospatial Occurrence of Similar Disorders

Perl, D. P., & Moalem, S. (2006) · Reviews in Mineralogy and Geochemistry · doi:10.2138/rmg.2006.64.4 · Cited by 16

Dopaminergic pharmacology and antioxidant properties of pukateine, a natural product lead for the design of agents increasing dopamine neurotransmission

Dajas‐Bailador, F., Asencio, M., Bonilla, C., Scorza, M. C., Echeverry, C., Reyes-Parada, M. I., Silveira, R., Protais, P., Russell, G. B., Cassels, B. K., et al. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00210-9 · Cited by 16

Oxidative Stress in Parkinson's Disease

Vaya, J., Aluf, Y., & Finberg, J. P. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9_12 · Cited by 16

Zinc increases the excitability of dopaminergic neurons in rat substantia nigra

Chung, J.-M., Chang, S.-Y., Kim, Y. I., & Shin, H.-C. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01120-4 · Cited by 16

Time-course and localization of transferrin receptor expression in the substantia nigra of 6-hydroxydopamine-induced parkinsonian rats

He, Y., Lee, T., & Leong, S. K. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00669-1 · Cited by 16

Cerebrospinal Fluid Iron‐Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease

Maass, F., Michalke, B., Willkommen, D., Canaslan, S., Schmitz, M., Bähr, M., Zerr, I., & Lingor, P. (2021) · Movement Disorders · doi:10.1002/mds.28790 · Cited by 15

ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism

Beauchamp, L. C., Liu, X. M., Vella, L. J., Adlard, P. A., Bush, A. I., Finkelstein, D. I., & Barnham, K. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01300-0 · Cited by 15

Manganese and Vanadium Co-Exposure Induces Severe Neurotoxicity in the Olfactory System: Relevance to Metal-Induced Parkinsonism

Ngwa, H. A., Bargues-Carot, A., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105285 · Cited by 15

The interplay between α-synuclein aggregation and necroptosis in Parkinson’s disease: a spatiotemporal perspective

Xiang, H. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1567445 · Cited by 18

Different Mechanisms Between Copper and Iron in Catecholamines-Mediated Oxidative DNA Damage and Disruption of Gene Expression In Vitro

Nishino, Y., Ando, M., Makino, R., Ueda, K., Okamoto, Y., & Kojima, N. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9226-7 · Cited by 15

Micronutrients and Risk of Parkinson’s Disease

Sherzai, A. Z., Tagliati, M., Park, K., Pezeshkian, S., & Sherzai, D. (2016) · Gerontology and Geriatric Medicine · doi:10.1177/2333721416644286 · Cited by 18

Modulation of Dopaminergic Neuronal Excitability by Zinc through the Regulation of Calcium-related Channels

Noh, J., & Chung, J.-M. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.5.578 · Cited by 15

α-Synuclein E46K Mutation and Involvement of Oxidative Stress in a Drosophila Model of Parkinson’s Disease

Jahromi, S. R., Ramesh, S. R., Finkelstein, D. I., & Haddadi, M. (2021) · Parkinson s Disease · doi:10.1155/2021/6621507 · Cited by 15

The distribution of copper, zinc- and manganese-superoxide dismutase, and glutathione peroxidase messenger ribonucleic acid in rat basal ganglia

Kunikowska, G., & Jenner, P. G. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00897-8 · Cited by 15

Differences in iron and manganese concentration may confound the measurement of myelin from R1 and R2 relaxation rates in studies of dysmyelination

Desmond, K. L., Al‐Ebraheem, A., Janik, R., Oakden, W., Kwiecień, J. M., Dąbrowski, W., Rola, R., Geraki, K., Farquharson, M., Stanisz, G. J., et al. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3549 · Cited by 15

Iron chelating agents with clinical potential

Hider, R. C., Singh, S., & Porter, J. B. (1992) · Proceedings of the Royal Society of Edinburgh Section B Biological Sciences · doi:10.1017/s0269727000013117 · Cited by 15

Reduced levels of catalase activity potentiate MPP+-induced toxicity: comparison between MN9D cells and CHO cells

Hussain, S. M., Hass, B. S., Slikker, W., & Ali, S. F. (1999) · Toxicology Letters · doi:10.1016/s0378-4274(98)00231-8 · Cited by 15

Comparison of the novel drug Ensaculin with MK-801 on the reduction of hydroxyl radical production in rat striatum after local application of glutamate

Teismann, P., & Ferger, B. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02395-1 · Cited by 15

Influence of iron-saturation of plasma transferrin in iron distribution in the brain

Takeda, A., Takatsuka, K., Sotogaku, N., & Oku, N. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00023-2 · Cited by 15

Significance of Transferrin in Iron Delivery to the Brain

Takeda, A. (2001) · Eisei kagaku · doi:10.1248/jhs.47.520 · Cited by 15

Effectiveness of QSM Over R2* in Assessment of Parkinson's Disease - A Systematic Review

Pendem, S., & Priyanka (2020) · Neurology India · doi:10.4103/0028-3886.284377 · Cited by 14

Subregional analysis of striatum iron in Parkinson’s disease and rapid eye movement sleep behaviour disorder

Alushaj, E., Hemachandra, D., Kuurstra, A. B., Menon, R. S., Ganjavi, H., Sharma, M., Kashgari, A., Barr, J., Reisman, W. M., KHAN, A. R., et al. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103519 · Cited by 15

Lack of increased oxidative stress in catechol-O-methyltransferase (COMT)-deficient mice

Forsberg, M., Juvonen, R. O., Helisalmi, P., Lepp�nen, J., Gogos, J. A., Karayiorgou, M., & Männistö, P. T. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0967-9 · Cited by 14

Dual function of Zn2+ on the intrinsic excitability of dopaminergic neurons in rat substantia nigra

Noh, J., Chang, S. Y., Wang, S. Y., & Chung, J.-M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.019 · Cited by 14

Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson’s Disease

Kim, Y., Choi, S. Y., Hwang, O., & Lee, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03017-9 · Cited by 14

On the effect of methionine oxidation on the interplay between α-synuclein and synaptic-like vesicles

Uceda, A. B., Frau, J., Vilanova, B., & Adrover, M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.12.262 · Cited by 15

Determination of the spatial distribution of major elements in the rat brain with X-ray fluorescence analysis

Takahashi, S., Hatashita, S., Taba, Y., Sun, X., Kubota, Y., & Yoshida, S. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(00)00231-4 · Cited by 14

Cell Culture Models of Neuronal Degeneration and Neuroprotection

Leonardi, E. T. K., & Mytilineou, C. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4869-0_12 · Cited by 14

Vitamin E and Other Antioxidants in Neurological Function and Disease

Muller, D. P. R. (1994) · Elsevier eBooks · doi:10.1016/b978-0-08-057168-3.50025-4 · Cited by 13

Synthetic neuromelanin is toxic to dopaminergic cell cultures

Nguyen, A., Gille, G., Moldzio, R., Hung, S.-T., & Rausch, W. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200054 · Cited by 14

l-DOPA exacerbates amphetamine-induced dopamine depletion

Myers, C. S., Witten, M. B., Yu, Y.-L., & Wagner, G. C. (1998) · Molecular and Chemical Neuropathology · doi:10.1007/bf02870183 · Cited by 14

Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats

Tarohda, T., Ishida, Y., Kawai, K., Yamamoto, M., & Amano, R. (2005) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-005-3423-x · Cited by 95

Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain

Genoud, S., Roberts, B. R., Gunn, A. P., Halliday, G. M., Lewis, S. J. G., Ball, H. J., Hare, D. J., & Double, K. L. (2017) · Metallomics · doi:10.1039/c7mt00244k · Cited by 126

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

Sofic, E., Riederer, P. F., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G. F., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 754

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia

Dexter, D. T., Jenner, P. G., Schapira, A. H. V., & MARSDEN, C. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320716 · Cited by 292

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537